Randomised Study to Compare the Effect of r-Hu-EPO Administration With Transfusion of Red Blood Cell Concentrates and Also With the Administration of Polyvitamins in Anemic and Tired Patients Presenting a Bad Prognostic in Middle Course

Gustave Roussy

Status and phase: Terminated; Phase 3

Conditions: - Medico-Economic Aspects (Evaluation of Medical Costs Related to the Three Strategies and Evaluation of Cost/Efficacy)

Treatments: Drug: Erythropoiétine

Study type: Interventional

Funder types: Other

Identifiers

NCT00180999

TUMFATIGUE

CSET 98/663

Details and patient eligibility

About

Randomised study to compare the effect of r-Hu-EPO administration with transfusion of Red Blood cell concentrates and also with the administration of polyvitamins in anemic and tired patients presenting a bad prognostic in middle course.

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Both sexes
• 18-70 yrs
• metastatic or locally advanced cancer
• Life expectancy > 3 months
• hemoglobin between 7 and 10 g/100ml
• no contraindication to r-Hu-EPO
• with written informed consent at entry time

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)